Is pediatric exclusivity working
暂无分享,去创建一个
[1] Eric L Eisenstein,et al. Economic return of clinical trials performed under the pediatric exclusivity program. , 2007, JAMA.
[2] J. Wit,et al. Stimulation programs for pediatric drug research – do children really benefit? , 2007, European Journal of Pediatrics.
[3] Robert M Califf,et al. Peer-reviewed publication of clinical trials completed for pediatric exclusivity. , 2006, JAMA.
[4] F. Djossou,et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] D. Murphy,et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. , 2003, JAMA.
[6] B. Lell,et al. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Wilson,et al. An update on the therapeutic orphan. , 1999, Pediatrics.
[8] G. Anabwani,et al. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children. , 1999, The Pediatric infectious disease journal.
[9] B. Lell,et al. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children , 1998, The Lancet.
[10] B. Sadler,et al. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.